Seth Ettenberg, Chief Scientific Officer at Unum Therapeutics Inc. (UMRX), sold 11,485 shares at $4.05 ($47K) on 2018-12-26, disclosed to the SEC on 2018-12-28.
Scheduled sale ($47k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UMRX | SELL | 2018-11-26 | $80K | — | Filing → |
| UMRX | SELL | 2018-10-29 | $194K | — | Filing → |
| UMRX | SELL | 2018-09-26 | $286K | — | Filing → |